EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, STOK:

05 Sep 2025
LAST:

20.68

CHANGE:
 1.05		OPEN:
19.82		HIGH:
20.90		ASK:
0.00		VOLUME:
543.6K
CHG(%):
5.35		PREV:
19.63		LOW:
19.55		BID:
0.00		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
05 Sep 2519.8220.9019.5520.68543.6K
04 Sep 2519.7319.8818.8019.63674.4K
03 Sep 2519.1820.4019.1119.771.37M
02 Sep 2519.7920.4519.3919.59986.3K
29 Aug 2520.0020.0019.3619.76623.5K
28 Aug 2519.3519.9719.0719.77684K
27 Aug 2519.3119.9719.2619.30599.7K
26 Aug 2518.2919.6618.0019.371.43M
25 Aug 2519.5119.8618.7818.87566.5K
22 Aug 2519.7319.9119.1319.561.15M

COMPANY PROFILE

Name:
About:Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, engages in the development of treatments for severe genetic diseases by upregulating protein expression. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output (TANGO) approach in developing antisense oligonucleotides (ASOs) to selectively restore protein levels. Its lead product candidates include STK-002, which is in preclinical stage for the treatment of autosomal dominant optic atrophy; and Zorevunersen (STK-001), an investigational new medicine for the treatment of Dravet syndrome is being evaluated in phase I/II clinical trials. The company also develops programs focused on various targets, including haploinsufficiency diseases of the central nervous system and eye. It has a license and collaboration with Biogen Inc. for the development and commercialization of zorevunersen medicine for the treatment of Dravet syndrome; and Acadia Pharmaceuticals Inc. for the discovery, development, and commercialization of novel RNA-based medicines for the treatment of genetic neurodevelopmental diseases. The company was formerly known as ASOthera Pharmaceuticals, Inc. and changed its name to Stoke Therapeutics, Inc. in May 2016. Stoke Therapeutics, Inc. was incorporated in 2014 and is headquartered in Bedford, Massachusetts.
Sector:Healthcare
Industry:Biotechnology
Address:45 Wiggins Avenue, Bedford, MA, United States, 01730
Website:https://www.stoketherapeutics.com
CUSIP:86150R107
CIK:0001623526
ISIN:US86150R1077
FIGI:BBG00JPCBPG9
LEI:549300RD25SS2DIJHJ67

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

P/E Ratio:21.25
Price to Book:3.03
Price to Sales:5.07
EBITDA:42.27M
Shares:54.8M
Market Cap:1.133B

TECHNICAL INDICATORS

MA5:19.89
MA10:19.63
MA20:18.22
MA50:14.76
MA100:12.41
MA200:11.09
STO9:89.16
STO14:90.87
RSI14:75.15
MTM14:2.17
ROC14:0.12
ATR:1.00
Week High:20.90
Week Low:18.80
Month High:20.90
Month Low:12.72
Year High:20.90
Year Low:5.35
Volatility:18.57